GlaxoSmithKline
Class action for Canadians who suffered adverse cardiovascular events from diabetes drugs Avandia, Avandamet, or Avandaryl.
ClosedOntario, QuebecDeadline: Deadline pendingEst. payout: Compensation pendingDeadline pending
About this settlement
A lawsuit for people who used certain diabetes drugs and suffered serious heart-related side effects.
This settled class action involved claims against GlaxoSmithKline for adverse cardiovascular events linked to the diabetes drugs Avandia, Avandamet, and Avandaryl (rosiglitazone) used in Canada since 2000. The claim period is closed, but affected individuals can review information and past documents online.
Who qualifies
- Persons residing in Canada who took or purchased rosiglitazone drugs (Avandia, Avandamet, Avandaryl) since March 21, 2000.
- Includes family members, successors, assigns, and dependants.
- Includes a subclass for residents of Quebec.
Compensation pending
Deadline Deadline pending